Stocks & Investing
Stocks and Investing
Stocks and Investing
Thu, October 13, 2022
[ Thu, Oct 13th 2022
] - WOPRAI
[ Thu, Oct 13th 2022
] - WOPRAI
[ Thu, Oct 13th 2022
] - WOPRAI
[ Thu, Oct 13th 2022
] - WOPRAI
[ Thu, Oct 13th 2022
] - WOPRAI
[ Thu, Oct 13th 2022
] - WOPRAI
[ Thu, Oct 13th 2022
] - WOPRAI
[ Thu, Oct 13th 2022
] - WOPRAI
[ Thu, Oct 13th 2022
] - WOPRAI
[ Thu, Oct 13th 2022
] - WOPRAI
[ Thu, Oct 13th 2022
] - WOPRAI
[ Thu, Oct 13th 2022
] - WOPRAI
[ Thu, Oct 13th 2022
] - WOPRAI
[ Thu, Oct 13th 2022
] - WOPRAI
[ Thu, Oct 13th 2022
] - WOPRAI
[ Thu, Oct 13th 2022
] - WOPRAI
[ Thu, Oct 13th 2022
] - WOPRAI
Wed, October 12, 2022
[ Wed, Oct 12th 2022
] - WOPRAI
[ Wed, Oct 12th 2022
] - WOPRAI
[ Wed, Oct 12th 2022
] - WOPRAI
[ Wed, Oct 12th 2022
] - WOPRAI
[ Wed, Oct 12th 2022
] - WOPRAI
[ Wed, Oct 12th 2022
] - WOPRAI
[ Wed, Oct 12th 2022
] - WOPRAI
[ Wed, Oct 12th 2022
] - WOPRAI
[ Wed, Oct 12th 2022
] - WOPRAI
[ Wed, Oct 12th 2022
] - WOPRAI
[ Wed, Oct 12th 2022
] - WOPRAI
[ Wed, Oct 12th 2022
] - WOPRAI
Mike Genovese Maintained (CALX) at Strong Buy with Increased Target to $75 on, Oct 12th, 2022
Mike Genovese of Rosenblatt, Maintained "Calix, Inc." (CALX) at Strong Buy with Increased Target from $65 to $75 on, Oct 12th, 2022.
Mike has made no other calls on CALX in the last 4 months.
There are 4 other peers that have a rating on CALX. Out of the 4 peers that are also analyzing CALX, 0 agree with Mike's Rating of Hold.
These are the ratings of the 4 analyists that currently disagree with Mike
- Christopher Howe of "Barrington Research" Maintained at Buy with Increased Target to $67 on, Wednesday, July 27th, 2022
- Paul Silverstein of "Cowen & Co." Maintained at Buy with Increased Target to $71 on, Wednesday, July 27th, 2022
- Ryan Koontz of "Needham" Maintained at Strong Buy with Increased Target to $63 on, Wednesday, July 27th, 2022
- George Notter of "Jefferies" Maintained at Strong Buy with Decreased Target to $61 on, Wednesday, June 22nd, 2022
